Difference between revisions of "Category:Protein expression-specific medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
 
m
Line 1: Line 1:
 +
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more measurable protein expression patterns (including the absence of a protein expression, e.g., triple-negative breast cancer).
 +
 
[[Category:Biomarker-specific medications]]
 
[[Category:Biomarker-specific medications]]

Revision as of 02:18, 2 May 2018

Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more measurable protein expression patterns (including the absence of a protein expression, e.g., triple-negative breast cancer).

Retrieved from "https://hemonc.org/w/index.php?title=Category:Protein_expression-specific_medications&oldid=26323"